SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001013762-23-002549
Filing Date
2023-10-06
Accepted
2023-10-06 16:30:30
Documents
2
Group Members
PASECO APS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea185891-13gabildgaard_reno.htm SC 13G 117338
2 JOINT FILING AGREEMENT ea185891ex99-1_renovaro.htm EX-99.1 8929
  Complete submission text file 0001013762-23-002549.txt   127906
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Subject) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-86428 | Film No.: 231314560
SIC: 2834 Pharmaceutical Preparations

Mailing Address VEDBAEK STRANDVEJ 506 VEDBAEK G7 2950
Business Address
Abildgaard Ole (Filed by) CIK: 0001994976 (see all company filings)

Type: SC 13G